Mounjaro 5mg Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management. It is taken once a week and helps with weight loss and blood sugar control.
People who have a personal or family history of MEN2 or medullary thyroid cancer (MTC) are not advised to use this injection. Because it could harm the unborn child, pregnant women should avoid it. They should also talk to their doctor about any prescription interactions.
Composition: Tirzepatide
Mechanism of Action:
A dual GIP and GLP-1 receptor agonist, tirzepatide aids in controlling blood sugar levels in people with type 2 diabetes. It functions by slowing stomach emptying, which raises satiety and may aid in weight loss, decreasing glucagon levels to lower blood sugar, and increasing insulin production in response to meal consumption.
Uses:
· Type-2 Diabetes Mellitus
· Weight Management
Dosage and Administration:
Given once a week as a subcutaneous injection. Depending on tolerance and individual response, the dosage may be changed.
Side Effects:
· Nausea
· Vomiting
· Diarrhea
· Constipation
· Decreased appetite
· Injection site reactions (Itching, Rashes)
· Hypoglycemia
Boost your visibility and reach more customers by listing your business with us. It's quick, easy, and absolutely free! Join thousands of businesses benefiting from our platform.
Add My Business arrow_forwardCopyright © 2026 Plumint.